Inactive Instrument

Press Releases Surface Oncology, Inc.

Equities

SURF

US86877M2098

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Coherus Completes Surface Oncology Acquisition	23-09-11	AQ
Surface Oncology : Coherus Completes Surface Oncology Acquisition - Form 8-K	23-09-08	PU
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences	23-08-31	AQ
SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF	23-08-07	BU
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023	23-08-02	AQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SURF, RETA, INPX	23-07-28	PR
Surface Oncology : Report of Independent Registered Public Accounting Firm - Form 8-K	23-07-03	PU
Coherus To Acquire Surface Oncology	23-06-26	AQ
SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF	23-06-21	BU
Shareholder Alert: Ademi LLP investigates whether Surface Oncology, Inc. has obtained a Fair Price in its transaction with Coherus	23-06-16	PR
SURF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surface Oncology, Inc. Is Fair to Shareholders	23-06-16	BU
Surface Oncology : Coherus to Acquire Surface Oncology - Form 8-K	23-06-16	PU
Coherus to Acquire Surface Oncology	23-06-16	AQ
SURFACE ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-05-04	AQ
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023	23-05-04	AQ
Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023	23-04-18	AQ
Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023	23-03-16	AQ
SURFACE ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-09	AQ
Surface Oncology : Results of Operations and Financial Condition - Form 8-K	23-03-09	PU
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022	23-03-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Surface Oncology, Inc.

Equities

SURF

US86877M2098

Press Releases

Filters